These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8704607)

  • 61. [The efficacy of isolated ultrafiltration and Capoten in the combined treatment of chronic heart failure].
    Sinopal'nikov VI; Kalashnikov VF
    Voen Med Zh; 1994 Nov; (11):30-2. PubMed ID: 7856136
    [No Abstract]   [Full Text] [Related]  

  • 62. [Chronic heart failure--speciale of treatment].
    Shilov AM; Dulaeva MS
    Kardiologiia; 2011; 51(9):29-34. PubMed ID: 21943006
    [No Abstract]   [Full Text] [Related]  

  • 63. [Combined administration of obzidan and sustak in the treatment of patients with chronic coronary insufficiency].
    Khalfen ESh; Sorokina VS; Iaikova MM
    Ter Arkh; 1974; 46(1):73-7. PubMed ID: 4217951
    [No Abstract]   [Full Text] [Related]  

  • 64. [Mildronate in geriatric patients with cardiac failure].
    Kalvinsh I; Visokinskas A; Bagdonas G; Knasene Iu; Lesaukaite V; Matsiyauskene Iu
    Ter Arkh; 2006; 78(9):75-7. PubMed ID: 17076229
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Therapy of perioperative nonseptic, noncardiogenic circulatory failure].
    Goertz A
    Klin Anasthesiol Intensivther; 1995; 47():129-38. PubMed ID: 7715170
    [No Abstract]   [Full Text] [Related]  

  • 66. [Clinical observation of the repeated use of isolated ultrafiltration in treating chronic circulatory insufficiency].
    Konovalov GA; Gruzdev AK; Mikhaĭlova NA; Denisov AIu; Popukaeva LM
    Ter Arkh; 1987; 59(9):130-2. PubMed ID: 3424178
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical evaluation of the combination of strophanthin and ATP in the therapy of chronic circulatory insufficiency].
    Karbasnikova GN
    Sov Med; 1974 Aug; 0(8):90-4. PubMed ID: 4428283
    [No Abstract]   [Full Text] [Related]  

  • 68. [The role of treatment compliance in combination therapy for heart failure and possibilities of its correction: generalization of Russian and world experience].
    Trofimov ES; Poskrebysheva AS
    Ter Arkh; 2014; 86(9):119-23. PubMed ID: 25518517
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Changes in myocardial contractility after insulin treatment of circulatory insufficiency].
    Tsintsadze GI; Abzianidze AD; Megreladze II; Ordzhonikidze SP
    Ter Arkh; 1980; 52(7):112-3. PubMed ID: 6996195
    [No Abstract]   [Full Text] [Related]  

  • 70. [Drugs in chronic heart failure. How many pills does the patient really need?].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Feb; 153(6):22, 24. PubMed ID: 21644333
    [No Abstract]   [Full Text] [Related]  

  • 71. [Severe chronic heart insufficiency. NYHA (New York Heart Association) stage III-IV. Aspects of treatment].
    Torvik D; Amlie JP; Ihlen H
    Tidsskr Nor Laegeforen; 1987 Sep; 107(27):2297-300. PubMed ID: 3445233
    [No Abstract]   [Full Text] [Related]  

  • 72. [Chorionic gonadotropin in the treatment of chronic circulatory failure in ischemic heart disease patients].
    Bondarenko IP
    Vrach Delo; 1984 Jul; (7):75-8. PubMed ID: 6475028
    [No Abstract]   [Full Text] [Related]  

  • 73. AR-L115BS in the treatment of heart failure.
    Thormann J; Kramer W; Schlepper M; Gottwick M
    Eur Heart J; 1982 Dec; 3 Suppl D():87-95. PubMed ID: 7160400
    [No Abstract]   [Full Text] [Related]  

  • 74. [Hepatoprotective preparations in the treatment of circulatory failure].
    Zvenigorodskaia LA; Speranskaia IE
    Sov Med; 1988; (3):67-71. PubMed ID: 3413555
    [No Abstract]   [Full Text] [Related]  

  • 75. [Consensus of experts on the role of ethyl esters of omega-3 polyunsaturated fatty acids for the treatment and prevention of chronic heart failure (conclusion of experts meeting, June 2011)].
    Belenkov IuN; Mareev VIu; Arutiunov GP; Shliakhto EV; Koziolova NA; Ageev FT; Tatarskiĭ BA; Lopatin IuM; Fomin IV; Kastanian AA; Ardashev AV; Giliarevskiĭ SR; Moiseev SV; Doshitsin VL; Linchak RM;
    Kardiologiia; 2011; 51(9):89-91. PubMed ID: 21943014
    [No Abstract]   [Full Text] [Related]  

  • 76. [Effects of molsidomine on hemodynamics for the patients with chronic heart failure (author's transl)].
    Hayasaki K; Tokunaga M; Kodama H; Kikuchi H; Matsunaga K; Ogata A; Ogawa T
    Kokyu To Junkan; 1981 Mar; 29(3):305-10. PubMed ID: 6894802
    [No Abstract]   [Full Text] [Related]  

  • 77. [Amrinone in the treatment of severe cardiac insufficiency].
    Suárez LD; Reader C; Guevara E; Delisio HJ
    Medicina (B Aires); 1985; 45(5):517-21. PubMed ID: 3916118
    [No Abstract]   [Full Text] [Related]  

  • 78. [Prazosin in chronic refractory cardiac insufficiency: results of continuous long-term therapy].
    Sánchez Domínguez J; Villa JG; Urbina Fuentes FJ; Menéndez Lozano A
    Rev Clin Esp; 1981 Apr; 161(2):113-7. PubMed ID: 7280315
    [No Abstract]   [Full Text] [Related]  

  • 79. [The characteristics of the action of mildronate (dihydrate 3-(2,2,2-trimethylhydrazine)propionate) on the red blood parameters in heart failure].
    Sisetskiĭ AP; Artiukh VP; Sakharchuk II; Starodub NF
    Eksp Klin Farmakol; 1992; 55(3):20-1. PubMed ID: 1458154
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Congestive heart failure--an overview.
    Hegde BM
    J Assoc Physicians India; 1993 Jun; 41(6):379-80. PubMed ID: 8005979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.